NCT06305923

Brief Summary

The goal of this clinical trial is to learn about colostrum as a cosmetic in mature skin. . The aim of the study was to examine the effect of a cosmetic preparation containing sheep colostrum on skin with signs of aging in mature women Participants will be given the creams and asked to apply one -two doses in the evening after nighttime facial cleaning. They were also asked to use sunscreens during the day. During the first visit and after eight weeks of everyday use of the tested cream, the skin parameters will be measured three times on both cheeks, and the results were averaged. Participants will be enrolled to the colostrum cream or base cream groups and will not be informed which group they belonged to.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2022

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

February 22, 2024

Completed
19 days until next milestone

First Posted

Study publicly available on registry

March 12, 2024

Completed
Last Updated

March 12, 2024

Status Verified

February 1, 2024

Enrollment Period

4 months

First QC Date

February 22, 2024

Last Update Submit

March 7, 2024

Conditions

Keywords

sheep colostrumskinhydrationTEWLfirmnessmature skin

Outcome Measures

Primary Outcomes (4)

  • hydration

    The skin was measured at standardized temperature and humidity using Courage + Khazaka electronic GmbH Multi Probe Adapter with the use of the aproporate probe. Hydratioan - measurement with corneometer, a capacitance method. The results are shown in in arbitrary units between 0 and 130. 1 CU =0,02 mg water in 1 cm2 epidermal stratum corneum

    8 weeks

  • transepidermal water loss

    The measurement is taken by Tewameter® TM probe: assessing transepidermal water loss. The results are shown in g/h/m2

    8 weeks

  • erythema and melanin content

    Mexameter® MX18 probe: measuring the level of hemoglobin (erythema) and melanin, the two main dyes responsible for skin color; a broad scale (0-999) of arbitrary Mexameter® units. The Mexameter ® MX 18 probe emits 3 specific light wavelengths. A receiver measures the reflection from the skin. As the quantity of emitted light is defined, the quantity of light absorbed by the skin can be calculated.

    8 weeks

  • sebum

    Sebumeter® SM 815 probe: measuring skin sebum level, independent of water content; results are shown as Sebumeter® units from 0-350 (approximated to μg/cm 2 in a certain range)

    8 weeks

Secondary Outcomes (2)

  • firmness of the skin

    8 weeks

  • firmness of the skin

    8 weeks

Study Arms (2)

placebo cream

PLACEBO COMPARATOR

everyday using of placebo cream

Other: placebo cream

colostrum cream

ACTIVE COMPARATOR

everyday using of colostrum cream

Other: colostrum cream

Interventions

the intervention in our study is everyday using a cream with active ingridient

colostrum cream

using a placebo cream

placebo cream

Eligibility Criteria

Age40 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Signs of skin aging: wrinkles, loss of skin elasticity, discolorations, dryness
  • Signed informed consent

You may not qualify if:

  • Pregnant or breastfeeding
  • Allergic to milk proteins
  • Suffer from neoplasms, contagious infections, autoimmunologic diseases
  • Suffer from face skin diseases
  • Have had an aesthetic procedure on the skin of the face during the last two months
  • Have been treated with isotretinoin or other oral retinoids during the last six months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Lodz

Lodz, 90-419, Poland

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 22, 2024

First Posted

March 12, 2024

Study Start

March 1, 2022

Primary Completion

June 30, 2022

Study Completion

July 31, 2022

Last Updated

March 12, 2024

Record last verified: 2024-02

Locations